Greenlee Heather, Kwan Marilyn L, Ergas Isaac Joshua, Sherman Karen J, Krathwohl Sarah E, Bonnell Christine, Lee Marion M, Kushi Lawrence H
Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th St., 7th Floor, New York, NY 10032, USA.
Breast Cancer Res Treat. 2009 Oct;117(3):653-65. doi: 10.1007/s10549-009-0315-3. Epub 2009 Jan 31.
Many women use complementary and alternative medicine (CAM) to maintain or improve their health. We describe CAM use among the first 1,000 participants enrolled in the Pathways Study, an ongoing prospective cohort study of women diagnosed with breast cancer (BC). Participants, identified by rapid case ascertainment in Kaiser Permanente Northern California, are women > or = 21 years diagnosed with first invasive BC. Comprehensive baseline data are collected on CAM use through in-person interviews. Study participants include 70.9% non-Hispanic whites, 10.2% Hispanics, 9.0% Asians, 6.5% African-Americans, and 3.4% others. Most women (82.2%) were diagnosed with AJCC stage I/II BC at average (+/-SD) age 59.5 (+/-12.0) years and reported prior use of at least one form of CAM (96.5% of participants). In the 5 years before diagnosis, CAM therapies used at least weekly by >20% of women included green tea, glucosamine, omega-3 fatty acids, prayer and religion. CAM use was high (86.1% of participants) in the period immediately following diagnosis; 47.5% used botanical supplements, 47.2% used other natural products, 28.8% used special diets, 64.2% used mind-body healing, and 26.5% used body/energy/other treatments. In multivariable analyses, frequent use of each CAM modality before and after diagnosis was associated with use of other CAM modalities and other health behaviors (i.e., high fruit/vegetable intake, lower BMI). CAM use before and after BC diagnosis is common in this diverse group of women. Our results emphasize the need for clinicians to discuss CAM use with all BC patients.
许多女性使用补充和替代医学(CAM)来维持或改善自身健康。我们描述了参与“路径研究”的首批1000名参与者中补充和替代医学的使用情况,该研究是一项正在进行的针对被诊断为乳腺癌(BC)的女性的前瞻性队列研究。通过在北加利福尼亚州凯撒医疗集团进行快速病例确诊来确定参与者,她们是年龄≥21岁、被诊断为首次侵袭性乳腺癌的女性。通过面对面访谈收集关于补充和替代医学使用情况的全面基线数据。研究参与者包括70.9%的非西班牙裔白人、10.2%的西班牙裔、9.0%的亚洲人、6.5%的非裔美国人以及3.4%的其他种族。大多数女性(82.2%)在平均(±标准差)年龄59.5(±12.0)岁时被诊断为美国癌症联合委员会(AJCC)I/II期乳腺癌,并且报告曾使用过至少一种形式的补充和替代医学(占参与者的96.5%)。在诊断前的5年中,超过20%的女性至少每周使用一次的补充和替代医学疗法包括绿茶、氨基葡萄糖、ω-3脂肪酸、祈祷和宗教活动。在诊断后紧接着的时期内,补充和替代医学的使用率很高(占参与者的86.1%);47.5%的人使用植物性补充剂,47.2%的人使用其他天然产品,28.8%的人采用特殊饮食,64.2%的人使用身心疗法,26.5%的人使用身体/能量/其他疗法。在多变量分析中,诊断前后频繁使用每种补充和替代医学模式都与使用其他补充和替代医学模式以及其他健康行为相关(即高水果/蔬菜摄入量、较低的体重指数)。在这群多样化的女性中,乳腺癌诊断前后使用补充和替代医学很常见。我们的结果强调临床医生需要与所有乳腺癌患者讨论补充和替代医学的使用情况。